Orazipone, with the CAS number 137109-78-5, is a chemical compound that belongs to the class of benzodiazepines. It is primarily recognized for its potential use in the treatment of various psychiatric disorders, particularly anxiety and depression. The compound exhibits a mechanism of action that involves modulation of the gamma-aminobutyric acid (GABA) receptor, which plays a crucial role in inhibitory neurotransmission in the central nervous system. Orazipone is characterized by its ability to enhance the effects of GABA, leading to anxiolytic and sedative properties. Additionally, it may possess neuroprotective effects, making it a subject of interest in pharmacological research. The compound's pharmacokinetics, including absorption, distribution, metabolism, and excretion, are essential for understanding its therapeutic potential and safety profile. As with many benzodiazepines, careful consideration of dosage and potential for dependence is necessary in clinical applications. Overall, Orazipone represents a significant area of study in the development of new treatments for mental health conditions.

Orazipone

137109-78-5: Orazipone, with the CAS number 137109-78-5, is a chemical compound that belongs to the class of benzodiazepines. It is primarily recognized for its potential use in the treatment of various psychiatric disorders, particularly anxiety and depression. The compound exhibits a mechanism of action that involves modulation of the gamma-aminobutyric acid (GABA) receptor, which plays a crucial role in inhibitory neurotransmission in the central nervous system. Orazipone is characterized by its ability to enhance the effects of GABA, leading to anxiolytic and sedative properties. Additionally, it may possess neuroprotective effects, making it a subject of interest in pharmacological research. The compound's pharmacokinetics, including absorption, distribution, metabolism, and excretion, are essential for understanding its therapeutic potential and safety profile. As with many benzodiazepines, careful consideration of dosage and potential for dependence is necessary in clinical applications. Overall, Orazipone represents a significant area of study in the development of new treatments for mental health conditions.

<p>Orazipone inhibits cytokine production and histamine release; an NSAID.</p>

CAS 137109-78-5

Orazipone

Orazipone

Ref: TM-T70843